Top Markets
Coin of the day
CYduct Diagnostics, Inc. CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc.

CYDX
Rang in Aktien #36385
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that... CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Aktienkurs
$0.5
Zuletzt synchronisiert: 2026-10-01
Marktkapitalisierung
$2.62M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
85.19%
Land
US
Handel CYduct Diagnostics, Inc. (CYDX)

Kategorie

Gewinn für CYduct Diagnostics, Inc. (CYDX)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von CYduct Diagnostics, Inc. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von CYduct Diagnostics, Inc. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B -
US
$5.56B -
IE
$5.15B -
US
$3.86B -
US
- -
DE